Lanean...
The Hidden Variable: A Case of Dasatinib-Induced Respiratory Failure
Tyrosine kinase inhibitors that target the BCR/ABL mutation have been used as therapies of BCR/ABL positive acute lymphoblastic leukemia (ALL) with significant results. Dasatinib is a multitargeted tyrosine kinase inhibitor with significant activity in Philadephia positive ALL which is resistant to...
Gorde:
| Argitaratua izan da: | Cureus |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Cureus
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7781781/ https://ncbi.nlm.nih.gov/pubmed/33415044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.11892 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|